KP Tissue Inc (KPT) Fair Value & Analysis
Consumer Defensive · CA · Market cap C$131M
Fair value as of: Jun 24, 2026
From 8 valuation models · updated 6 days ago
Fair value updated Jun 24, 2026 — revised from C$13.47 to C$17.81 (+32.2%) since Jun 23, 2026. Share price +8.4% over the past month.
Price vs Fair Value (12 months)
12‑month range C$8.51 – C$13.92 · fair‑value band C$13.36 – C$22.26 · the C$13.52 price screens below the C$17.81 fair value. As of Jun 24, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
KP Tissue Inc (KPT) currently trades at C$13.52, while our model-based Fair Value estimate is C$17.81 — implying the stock looks roughly 31.7% undervalued today. We read business quality at 89/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
It earns a return on equity of 12.2%. The stock trades on a trailing P/E of 14.5. Fundamentals as of Jun 24, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
KP Tissue Inc., through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through the Consumer and Away-From-Home segments. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under Cashmere, Purex, Scotties, SpongeTowels, Bonterra and White Cloud. brand names, as well as under private labels. It sells its products through the retail channels, such as grocery stores, mass merchandisers, club stores, drug stores, and convenience stores; and distributors to businesses involved in property management, health care, food service, manufacturing and lodging, education, and lodging. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
KP Tissue Inc reported revenue of C$0 in FY2025 versus C$0 in FY2021. Reported net income was C$8.5M in FY2025, compounding +61.9%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | 2,590 MXN | 1,415 MXN | -45% |
| L'Oréal S.A LRLCF | $428.02 | $273.79 | -36% |
| Unilever PLC UNLYF | $59.34 | $46.11 | -22% |
| Colgate-Palmolive Company CPA | €77.60 | €36.69 | -53% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,185 | ₹1,000 | -54% |
| Reckitt Benckiser Group RBGLY | $12.41 | $17.31 | +39% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is KP Tissue Inc (KPT) undervalued?
What is the fair value of KPT?
What is the quality score of KPT?
What is the net profit margin of KPT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.